 Aneta Gandjeva
Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 10 | 2024 | 1894 | 0.790 |
Why?
| | Histological Techniques | 1 | 2018 | 40 | 0.570 |
Why?
| | Lung | 9 | 2024 | 3927 | 0.530 |
Why?
| | Vascular Remodeling | 6 | 2024 | 192 | 0.510 |
Why?
| | Hypoxia | 7 | 2024 | 1084 | 0.500 |
Why?
| | Pulmonary Artery | 7 | 2024 | 1095 | 0.420 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2023 | 274 | 0.320 |
Why?
| | Disease Models, Animal | 11 | 2024 | 4057 | 0.310 |
Why?
| | Pulmonary Veno-Occlusive Disease | 1 | 2024 | 12 | 0.230 |
Why?
| | Pulmonary Emphysema | 2 | 2020 | 275 | 0.210 |
Why?
| | Sirtuin 3 | 1 | 2023 | 58 | 0.200 |
Why?
| | Pneumonia | 2 | 2020 | 616 | 0.190 |
Why?
| | Acute Lung Injury | 2 | 2017 | 279 | 0.190 |
Why?
| | Fibroblasts | 3 | 2023 | 948 | 0.190 |
Why?
| | Scleroderma, Systemic | 1 | 2022 | 114 | 0.180 |
Why?
| | Dendritic Cells | 1 | 2024 | 479 | 0.180 |
Why?
| | Extracellular Matrix | 1 | 2024 | 502 | 0.170 |
Why?
| | Laser Capture Microdissection | 2 | 2018 | 24 | 0.170 |
Why?
| | Endothelial Cells | 3 | 2023 | 746 | 0.170 |
Why?
| | Platelet Activation | 1 | 2020 | 91 | 0.170 |
Why?
| | Transcription Factors | 3 | 2014 | 1647 | 0.170 |
Why?
| | Mice, Inbred C57BL | 5 | 2024 | 5439 | 0.160 |
Why?
| | Animals | 18 | 2024 | 35309 | 0.150 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 235 | 0.150 |
Why?
| | Pulmonary Alveoli | 3 | 2017 | 400 | 0.150 |
Why?
| | Mice, Knockout | 8 | 2020 | 2871 | 0.150 |
Why?
| | Rats | 6 | 2024 | 5482 | 0.140 |
Why?
| | Blood Platelets | 1 | 2020 | 380 | 0.140 |
Why?
| | Mice | 13 | 2024 | 16915 | 0.140 |
Why?
| | Complement Activation | 1 | 2020 | 381 | 0.130 |
Why?
| | Alveolar Epithelial Cells | 1 | 2017 | 106 | 0.130 |
Why?
| | MicroRNAs | 1 | 2022 | 676 | 0.130 |
Why?
| | DNA-Binding Proteins | 2 | 2014 | 1446 | 0.130 |
Why?
| | Schistosomiasis mansoni | 1 | 2015 | 23 | 0.120 |
Why?
| | Immunoglobulin G | 1 | 2020 | 848 | 0.120 |
Why?
| | Interleukin-4 | 1 | 2015 | 212 | 0.120 |
Why?
| | Interleukin-13 | 1 | 2015 | 147 | 0.110 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2014 | 396 | 0.110 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1691 | 0.110 |
Why?
| | Macrophages | 2 | 2024 | 1484 | 0.100 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 155 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2024 | 199 | 0.100 |
Why?
| | Glycocalyx | 1 | 2012 | 21 | 0.100 |
Why?
| | Pulmonary Veins | 1 | 2013 | 98 | 0.100 |
Why?
| | Ceramides | 1 | 2012 | 112 | 0.090 |
Why?
| | Endotoxemia | 1 | 2012 | 86 | 0.090 |
Why?
| | Inflammation | 5 | 2024 | 2737 | 0.090 |
Why?
| | Cattle | 2 | 2024 | 977 | 0.090 |
Why?
| | Nerve Growth Factors | 1 | 2011 | 73 | 0.090 |
Why?
| | Heart Diseases | 1 | 2013 | 350 | 0.080 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2020 | 147 | 0.080 |
Why?
| | Humans | 16 | 2024 | 129266 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 314 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2023 | 374 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2013 | 901 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 442 | 0.070 |
Why?
| | Neutrophils | 1 | 2012 | 1207 | 0.070 |
Why?
| | Smoking | 2 | 2012 | 1499 | 0.060 |
Why?
| | Phosphorylation | 2 | 2024 | 1710 | 0.060 |
Why?
| | Mitomycin | 1 | 2024 | 32 | 0.060 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2024 | 26 | 0.060 |
Why?
| | eIF-2 Kinase | 1 | 2024 | 30 | 0.060 |
Why?
| | Protein Phosphatase 1 | 1 | 2024 | 33 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2024 | 2396 | 0.060 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2024 | 145 | 0.050 |
Why?
| | Signal Transduction | 1 | 2017 | 4926 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2024 | 143 | 0.050 |
Why?
| | Apoptosis | 1 | 2012 | 2499 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2011 | 790 | 0.050 |
Why?
| | NAD | 1 | 2023 | 75 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 2 | 2014 | 376 | 0.050 |
Why?
| | Monocrotaline | 1 | 2022 | 28 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 328 | 0.050 |
Why?
| | Imatinib Mesylate | 1 | 2022 | 76 | 0.050 |
Why?
| | Male | 8 | 2024 | 63512 | 0.050 |
Why?
| | Immunoenzyme Techniques | 2 | 2013 | 214 | 0.050 |
Why?
| | Complement System Proteins | 1 | 2024 | 317 | 0.050 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 248 | 0.050 |
Why?
| | Deferoxamine | 1 | 2020 | 20 | 0.040 |
Why?
| | Chemokine CCL5 | 1 | 2020 | 43 | 0.040 |
Why?
| | Iron Chelating Agents | 1 | 2020 | 18 | 0.040 |
Why?
| | Platelet Factor 4 | 1 | 2020 | 34 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2023 | 4077 | 0.040 |
Why?
| | Hepatocyte Growth Factor | 1 | 2020 | 34 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2014 | 399 | 0.040 |
Why?
| | Pericytes | 1 | 2020 | 28 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 947 | 0.040 |
Why?
| | Female | 7 | 2024 | 68551 | 0.040 |
Why?
| | Complement C5 | 1 | 2020 | 78 | 0.040 |
Why?
| | Phenotype | 2 | 2023 | 3074 | 0.040 |
Why?
| | Microvessels | 1 | 2020 | 82 | 0.040 |
Why?
| | Blotting, Western | 2 | 2013 | 1204 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2012 | 812 | 0.040 |
Why?
| | Pyrroles | 1 | 2020 | 202 | 0.040 |
Why?
| | Immunoglobulins | 1 | 2020 | 160 | 0.040 |
Why?
| | Smoke | 1 | 2020 | 139 | 0.040 |
Why?
| | Fatty Acids | 1 | 2022 | 427 | 0.040 |
Why?
| | Complement Factor B | 1 | 2020 | 108 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2020 | 220 | 0.040 |
Why?
| | Complement Pathway, Alternative | 1 | 2020 | 119 | 0.040 |
Why?
| | Thrombocytopenia | 1 | 2020 | 186 | 0.040 |
Why?
| | Complement C3 | 1 | 2020 | 208 | 0.040 |
Why?
| | Pulmonary Circulation | 1 | 2020 | 430 | 0.040 |
Why?
| | Transcriptome | 1 | 2024 | 874 | 0.040 |
Why?
| | Proteomics | 1 | 2024 | 1054 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2017 | 2375 | 0.040 |
Why?
| | Indoles | 1 | 2020 | 384 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2024 | 1688 | 0.030 |
Why?
| | Mitochondria | 1 | 2023 | 877 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2017 | 79 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 83 | 0.030 |
Why?
| | Age Factors | 1 | 2024 | 3140 | 0.030 |
Why?
| | Permeability | 1 | 2017 | 157 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2022 | 890 | 0.030 |
Why?
| | Interleukin-4 Receptor alpha Subunit | 1 | 2015 | 8 | 0.030 |
Why?
| | STAT6 Transcription Factor | 1 | 2015 | 26 | 0.030 |
Why?
| | Smad3 Protein | 1 | 2015 | 43 | 0.030 |
Why?
| | Smad2 Protein | 1 | 2015 | 38 | 0.030 |
Why?
| | Schistosoma mansoni | 1 | 2015 | 37 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2013 | 0.030 |
Why?
| | Th17 Cells | 1 | 2015 | 83 | 0.030 |
Why?
| | Th1 Cells | 1 | 2015 | 137 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2013 | 2703 | 0.030 |
Why?
| | Wound Healing | 1 | 2017 | 306 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 173 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2017 | 530 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 275 | 0.030 |
Why?
| | Aging | 1 | 2024 | 1774 | 0.030 |
Why?
| | Receptors, Urokinase Plasminogen Activator | 1 | 2013 | 15 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 119 | 0.030 |
Why?
| | Endotoxins | 1 | 2014 | 220 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 455 | 0.030 |
Why?
| | Lung Compliance | 1 | 2012 | 46 | 0.030 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 983 | 0.020 |
Why?
| | Glucuronidase | 1 | 2012 | 44 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 87 | 0.020 |
Why?
| | Heparitin Sulfate | 1 | 2012 | 42 | 0.020 |
Why?
| | Middle Aged | 3 | 2024 | 31090 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 86 | 0.020 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2012 | 107 | 0.020 |
Why?
| | Intestinal Perforation | 1 | 2012 | 45 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2012 | 135 | 0.020 |
Why?
| | Airway Remodeling | 1 | 2012 | 61 | 0.020 |
Why?
| | Endothelium | 1 | 2012 | 121 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2012 | 218 | 0.020 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 58 | 0.020 |
Why?
| | Emphysema | 1 | 2012 | 109 | 0.020 |
Why?
| | Netrin-1 | 1 | 2011 | 12 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2779 | 0.020 |
Why?
| | Epoprostenol | 1 | 2012 | 136 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 3773 | 0.020 |
Why?
| | Sex Distribution | 1 | 2012 | 359 | 0.020 |
Why?
| | Adult | 3 | 2024 | 35495 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2012 | 452 | 0.020 |
Why?
| | Kidney Function Tests | 1 | 2011 | 152 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2012 | 296 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1288 | 0.020 |
Why?
| | Creatinine | 1 | 2011 | 491 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2117 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 833 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 877 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2012 | 313 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1090 | 0.020 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 485 | 0.020 |
Why?
| | Heart-Assist Devices | 1 | 2013 | 539 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2011 | 711 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1202 | 0.020 |
Why?
| | Homeostasis | 1 | 2010 | 605 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2012 | 1063 | 0.020 |
Why?
| | NF-kappa B | 1 | 2010 | 665 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2012 | 1266 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3377 | 0.020 |
Why?
| | Aged | 2 | 2013 | 22032 | 0.010 |
Why?
| | Kidney | 1 | 2011 | 1385 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2537 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 5409 | 0.010 |
Why?
| | Prospective Studies | 1 | 2013 | 7123 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 12391 | 0.010 |
Why?
| | Adolescent | 1 | 2013 | 20313 | 0.010 |
Why?
| | Child | 1 | 2013 | 20785 | 0.010 |
Why?
|
|
Gandjeva's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|